Results showed dose-dependent weight loss: the 0.25mg dose produced 4.5% additional weight loss beyond diet and placebo, the 0.5mg dose achieved 9.2% weight loss, and the 1.0mg dose resulted in 10.6% weight lossrepresenting approximately twice the efficacy of other approved obesity drugs available at that time
Khan F, Mat A, Hogan AE, et al
It can only be accessed through approved clinical trials, which can be found via the NIHR 'Be Part of Research' portal
Regular checkups and cleanings help catch problems early, when theyre easier and less expensive to fix
Tirzepatide functions as an imbalanced dual agonist, characterised by a molecular structure exhibiting a markedly higher affinity for the GIP receptor than the GLP-1 receptor
The negative reviews are similar to those from the BBB page and mainly involve difficulty either contacting customer service or canceling subscriptions